Analyst Consensus ?
ConsensusHold49 ratings
Bullish2346.9%
Neutral2142.9%
Bearish510.2%
1 unmapped firm rating excluded from the percentages.
Cognizant Technology Solutions Corporation · CTSH · FY2025 Q1 · Calendar Q2 2025
Cognizant pairs AI investment with steady guidance and margin focus
The supplied analysis supports a cautiously constructive view of Cognizant’s operating trajectory: AI productivity, demand in Health Sciences and Financial Services, and acquisitions provide growth support, while maintained guidance and margin expansion are counterbalanced by macro, pricing, wage, and execution risks.
Reported After market closeNASDAQTechnology
$25.77B market cap
80quality score
Earnings scorecard
Reported versus consensus
Reported EPS
—
Consensus $1.19
EPS surprise
—
Reported versus consensus
Reported revenue
—
Consensus $5.06B
Revenue surprise
—
Reported versus consensus
Market reaction
event-close to next-session close
Stock move
+2.3%
Event window
SPY move
+0.7%
Same window
Abnormal move
+1.5%
Stock minus SPY
Volume
1.8×
Versus trailing sessions
Subsequent drift
+7.7%
Up to 20 sessions
CTSHSPY benchmark
Ask FN2 about CTSH FY2025 Q1
Transcript, numbers and history already loaded
What drove CTSH's +2.3% move after FY2025 Q1 earnings?What changed in CTSH's guidance and outlook in FY2025 Q1?Give me the bull and bear case for CTSH after FY2025 Q1 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Relative to the prior analysis, the current analysis adds emphasis on AI productivity at scale, the NVIDIA relationship, a larger enterprise AI pipeline, and continued investment in training and capability centers. The risk picture remains centered on macro uncertainty, pricing, wage costs, and execution.
Guidance delta
Maintained; the supplied analysis says full-year revenue guidance remained unchanged despite macro uncertainty.
Key takeaways
- The current analysis describes growth led by Health Sciences, Financial Services, and the Belcan acquisition.
- Management emphasized AI-led productivity, large and mega deals, and partnerships supporting enterprise AI offerings.
- The central tension is whether utilization and AI productivity can offset pricing, wage, and macro pressures.
Management priorities
- Scale AI capabilities through the Neuro AI platform and the NVIDIA partnership.
- Build AI skills through the Chennai learning center and expand Global Capability Center relationships.
- Continue opportunistic M&A and invest in engineering and pharmaceutical technology capabilities.
Follow CTSH with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$57.22Previous close
$44Low
$73.35Average
$107High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Oct 7, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wedbush | Outperform | Outperform | Maintain | Oct 2, 2026 |
| TD Cowen | Hold | Hold | Maintain | Sep 18, 2026 |
| Deutsche Bank | Buy | Buy | Maintain | Sep 18, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Jul 30, 2026 |
| Susquehanna | Positive | Positive | Maintain | Jul 30, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jul 30, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Jul 30, 2026 |
| Guggenheim | Buy | Buy | Maintain | Jul 27, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Jul 24, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jul 24, 2026 |
| Baird | Neutral | Neutral | Maintain | Jul 10, 2026 |
| Mizuho | Neutral | Neutral | Maintain | May 6, 2026 |
| UBS | Neutral | Neutral | Maintain | Apr 13, 2026 |
| William Blair | Outperform | Market Perform | Upgrade | Nov 21, 2025 |
| TD Securities | Hold | Hold | Maintain | May 1, 2025 |
| Needham | Hold | Hold | Maintain | May 1, 2025 |
| BMO Capital | Market Perform | Market Perform | Maintain | May 1, 2025 |
| Barclays | Overweight | Overweight | Maintain | Apr 25, 2025 |
| Goldman Sachs | Neutral | Neutral | Maintain | Sep 12, 2024 |
| B of A Securities | Neutral | Underperform | Upgrade | Aug 7, 2024 |
| Evercore ISI Group | In Line | In Line | Maintain | Mar 26, 2024 |
| Jefferies | Buy | Hold | Upgrade | Jan 11, 2024 |
| Societe Generale | Sell | Hold | Downgrade | Jan 5, 2024 |
| Wolfe Research | Peer Perform | Underperform | Upgrade | Jan 4, 2024 |
| HSBC | Buy | Hold | Upgrade | May 5, 2023 |
| MoffettNathanson | Underperform | Market Perform | Downgrade | Jan 19, 2023 |
| Cowen & Co. | Market Perform | Outperform | Downgrade | Jul 28, 2022 |
| Berenberg | Hold | Hold | Maintain | Feb 2, 2021 |
| Credit Suisse | Outperform | Outperform | Maintain | Dec 29, 2020 |
| Atlantic Equities | Underweight | Underweight | Maintain | Feb 19, 2020 |
| Ambit Capital | Sell | Sell | Maintain | Dec 23, 2019 |
| Edward Jones | Buy | Hold | Upgrade | Nov 11, 2019 |
| Argus Research | Hold | Buy | Downgrade | May 10, 2019 |
| Argus | Hold | Buy | Downgrade | May 10, 2019 |
| Keybanc | Overweight | Downgrade | May 3, 2019 | |
| Bernstein | Outperform | Market Perform | Upgrade | Jan 25, 2019 |
| Bank of America | Underperform | Underperform | Maintain | Nov 2, 2018 |
| Nomura | Neutral | Neutral | Maintain | Feb 8, 2018 |
| Pivotal Research | Buy | Buy | Maintain | Nov 8, 2017 |
| Loop Capital | Buy | Hold | Upgrade | Aug 4, 2017 |
| SunTrust Robinson Humphrey | Buy | Hold | Upgrade | Apr 13, 2017 |
| CLSA | Buy | Buy | Maintain | Sep 14, 2016 |
| Pacific Crest | Overweight | Overweight | Maintain | Jul 12, 2016 |
| Sterne Agee CRT | Neutral | Neutral | Maintain | Dec 17, 2015 |
| Oppenheimer | Outperform | Outperform | Maintain | May 4, 2015 |
| Tigress Financial | Buy | Buy | Maintain | Oct 17, 2013 |
| Evercore Partners | Overweight | Overweight | Maintain | Apr 15, 2013 |
| PiperJaffray | Overweight | Overweight | Maintain | Nov 23, 2012 |
| Piper Sandler | Overweight | Overweight | Maintain | Nov 23, 2012 |
| BGB Securities | Hold | Hold | Maintain | May 7, 2012 |
Named analyst price targets
Upside is calculated against the persisted previous close $57.22. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Mizuho Securities | Dan Dolev | $64 | $55.78 | +11.8% | Aug 6, 2026 |
| Susquehanna | Analyst unavailable | $82 | $52.4 | +43.3% | Jul 30, 2026 |
| Robert W. Baird | Analyst unavailable | $68 | $52.39 | +18.8% | Jul 30, 2026 |
| Morgan Stanley | James Faucette | $51 | $52.24 | -10.9% | Jul 30, 2026 |
| Guggenheim | Analyst unavailable | $65 | $45.45 | +13.6% | Jul 27, 2026 |
| RBC Capital | Analyst unavailable | $55 | $43.01 | -3.9% | Jul 24, 2026 |
| RBC Capital | Daniel Perlin | $47 | $43.01 | -17.9% | Jul 24, 2026 |
| Deutsche Bank | Analyst unavailable | $55 | $43.4 | -3.9% | Jul 10, 2026 |
| Robert W. Baird | Analyst unavailable | $55 | $43.4 | -3.9% | Jul 10, 2026 |
| Wells Fargo | Analyst unavailable | $61 | $43.4 | +6.6% | Jul 10, 2026 |
| Morgan Stanley | Analyst unavailable | $44 | $41.83 | -23.1% | Jun 23, 2026 |
| Berenberg Bank | Analyst unavailable | $59 | $51.05 | +3.1% | Jun 17, 2026 |
| Wedbush | Steven Wahrhaftig | $70 | $53.21 | +22.3% | Jun 8, 2026 |
| Truist Financial | Arvind Ramnani | $66 | $55.76 | +15.3% | Jun 1, 2026 |
| Mizuho Securities | Analyst unavailable | $68 | $51.87 | +18.8% | May 6, 2026 |
| Susquehanna | Analyst unavailable | $88 | $52.9 | +53.8% | May 1, 2026 |
| Morgan Stanley | James Faucette | $63 | $52.42 | +10.1% | Apr 30, 2026 |
| Wedbush | Analyst unavailable | $56 | $54.7 | -2.1% | Apr 30, 2026 |
| Goldman Sachs | Analyst unavailable | $75 | $54.7 | +31.1% | Apr 29, 2026 |
| Morgan Stanley | Analyst unavailable | $70 | $55.08 | +22.3% | Apr 27, 2026 |
| Robert W. Baird | Analyst unavailable | $72 | $57.44 | +25.8% | Apr 10, 2026 |
| Wedbush | Analyst unavailable | $61 | $59.2 | +6.6% | Apr 9, 2026 |
| UBS | Analyst unavailable | $71 | $61.02 | +24.1% | Mar 13, 2026 |
| BMO Capital | Analyst unavailable | $83 | $69.56 | +45.1% | Feb 12, 2026 |
| Mizuho Securities | Dan Dolev | $87 | $77.08 | +52.0% | Feb 9, 2026 |
| Morgan Stanley | Analyst unavailable | $82 | $76.71 | +43.3% | Feb 5, 2026 |
| BMO Capital | Analyst unavailable | $96 | $83.3 | +67.8% | Jan 29, 2026 |
| Guggenheim | Jonathan Lee | $100 | $84.65 | +74.8% | Jan 28, 2026 |
| Deutsche Bank | Analyst unavailable | $100 | $84.18 | +74.8% | Jan 26, 2026 |
| Susquehanna | James Friedman | $98 | $84.54 | +71.3% | Jan 23, 2026 |
| Berenberg Bank | Meha Pau | $107 | $84.03 | +87.0% | Jan 22, 2026 |
| Wells Fargo | Analyst unavailable | $98 | $84.47 | +71.3% | Jan 14, 2026 |
| UBS | Analyst unavailable | $82 | $80.72 | +43.3% | Dec 8, 2025 |
| UBS | Analyst unavailable | $78 | $71.82 | +36.3% | Oct 30, 2025 |
| Mizuho Securities | Dan Dolev | $85 | $71.69 | +48.5% | Oct 30, 2025 |
| Goldman Sachs | James Schneider | $84 | $67.82 | +46.8% | Oct 29, 2025 |
| Wells Fargo | Jason Kupferberg | $82 | $68.77 | +43.3% | Oct 21, 2025 |
| Guggenheim | Jonathan Lee | $85 | $66.7 | +48.5% | Oct 21, 2025 |
| Barclays | Ramsey El-Assal | $95 | $80.06 | +66.0% | Dec 17, 2024 |
| Mizuho Securities | Dan Dolev | $83 | $74.98 | +45.1% | Oct 29, 2024 |
| Deutsche Bank | Bryan Keane | $80 | $76.87 | +39.8% | Oct 22, 2024 |
| Goldman Sachs | James Schneider | $76 | $76.3 | +32.8% | Sep 11, 2024 |
| RBC Capital | Daniel Perlin | $82 | $77.27 | +43.3% | Aug 28, 2024 |
| Bank of America Securities | Jason Kupferberg | $75 | $72.65 | +31.1% | Aug 7, 2024 |
| BMO Capital | Keith Bachman | $85 | $75.68 | +48.5% | Aug 1, 2024 |
| Goldman Sachs | James Schneider | $72 | $68.34 | +25.8% | Jun 24, 2024 |
| Deutsche Bank | Bryan Keane | $70 | $67.25 | +22.3% | Jun 10, 2024 |
| BMO Capital | Keith Bachman | $77 | $65.68 | +34.6% | Apr 30, 2024 |
| Morgan Stanley | James Faucette | $65 | $69.26 | +13.6% | Apr 12, 2024 |
| Jefferies | Surinder Thind | $85 | $74.88 | +48.5% | Jan 11, 2024 |
| Susquehanna | Analyst unavailable | $91 | $69.04 | +59.0% | Feb 3, 2023 |
| Morgan Stanley | Analyst unavailable | $60 | $70.66 | +4.9% | Feb 3, 2023 |
| UBS | Rayna Kumar | $68 | $64.06 | +18.8% | Jan 15, 2023 |
| BMO Capital | Analyst unavailable | $71 | $65.1 | +24.1% | Jan 13, 2023 |
| J.P. Morgan | Analyst unavailable | $62 | $58.23 | +8.4% | Dec 15, 2022 |
| Barclays | Ramsey El-Assal | $45 | $52.63 | -21.4% | Nov 6, 2022 |
| BMO Capital | Keith Bachman | $65 | $51.96 | +13.6% | Nov 3, 2022 |
| RBC Capital | Daniel Perlin | $66 | $51.96 | +15.3% | Nov 3, 2022 |
| BMO Capital | Keith Bachman | $65 | $60.26 | +13.6% | Nov 3, 2022 |
| RBC Capital | Daniel Perlin | $66 | $60.26 | +15.3% | Nov 3, 2022 |
| Robert W. Baird | David Koning | $66 | $60.26 | +15.3% | Nov 3, 2022 |
| UBS | Rayna Kumar | $62 | $51.96 | +8.4% | Nov 3, 2022 |
| HSBC | Yogesh Aggarwal | $79 | $68.95 | +38.1% | Aug 17, 2022 |
| RBC Capital | Daniel Perlin | $88 | $67.07 | +53.8% | Jul 28, 2022 |
| Robert W. Baird | David Koning | $84 | $69.44 | +46.8% | Jul 27, 2022 |
| Morgan Stanley | James Faucette | $75 | $69.21 | +31.1% | Jul 22, 2022 |
| Morgan Stanley | James Faucette | $90 | $84.36 | +57.3% | May 5, 2022 |
| BMO Capital | Keith Bachman | $100 | $89.17 | +74.8% | Feb 8, 2022 |
| Morgan Stanley | James Faucette | $95 | $86.94 | +66.0% | Jan 13, 2022 |
| Goldman Sachs | Brian Essex | $104 | $86.42 | +81.8% | Jan 9, 2022 |
| Susquehanna | James Friedman | $100 | $81.74 | +74.8% | Nov 19, 2021 |
| UBS | Diviya Nagarajan | $58.5 | $72.89 | +2.2% | Aug 4, 2021 |
| Societe Generale | Richard Nguyen | $92 | $73.25 | +60.8% | Jul 29, 2021 |
| Nomura | Rishit Parikh | $80 | $73.25 | +39.8% | Jul 29, 2021 |
| HSBC | Yogesh Aggarwal | $90 | $67.49 | +57.3% | Jul 22, 2021 |
Track every rating change on CTSH the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationCognizant Technology Solutions Corporation functions as a global professional services firm, delivering a comprehensive suite of consulting, technology, and outsourcing solutions across North America, Europe, and other international markets. Its operations are structured into four primary divisions: Financial Services, Healthcare, Products and Resources, and Communications, Media and Technology. Within the Financial Services sector, Cognizant provides advanced services such as enhancing customer experiences, implementing robotic process automation (RPA), and leveraging analytics and artificial intelligence (AI) to address needs in areas like digital lending, fraud prevention, and modern payment systems. For its Healthcare clients, the company focuses on navigating industry shifts toward consumer-centric models, outcome-based agreements, and digital health initiatives, striving to deliver an integrated, seamless, and patient-focused omnichannel experience.…
Historical context
All CTSH earningsTechnology peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| ACN Accenture plc | FY2026 Q4 · Calendar Q4 2026 | +3.5% | +15.8% | Accenture: AI demand supports strong Q4, while pricing and geopolitics remain risks |
| JBL Jabil Inc. | FY2026 Q4 · Calendar Q3 2026 | +8.1% | -10.0% | Jabil enters FY2027 with AI-led growth and capacity risks |
| MU Micron Technology, Inc. | FY2026 Q4 · Calendar Q3 2026 | +5.4% | +0.0% | Micron: Strong AI Memory Demand, Higher Capex, and HBM4E Ahead |
| SNX TD Synnex Corp | FY2026 Q3 · Calendar Q3 2026 | +20.9% | -9.9% | TD SYNNEX: AI-led growth accelerates, but mix and cash flow matter |
| ADBE Adobe Inc. | FY2026 Q3 · Calendar Q3 2026 | +0.8% | +1.4% | Adobe raises FY26 outlook as AI strategy broadens |
| ORCL Oracle Corporation | FY2027 Q1 · Calendar Q3 2026 | +10.3% | -1.7% | Oracle raises FY27 outlook as AI demand accelerates cloud growth |
Latest beats and misses
Who reports nextBeat on EPS
- LWFY2027 Q1 · October 6, 2026+27.8% EPS+7.5% move
- RPMFY2027 Q1 · October 6, 2026+1.5% EPS+3.2% move
- ACNFY2026 Q4 · October 1, 2026+3.5% EPS+15.8% move
- MKCFY2026 Q3 · October 1, 2026+13.9% EPS-4.9% move
- NKEFY2027 Q1 · October 1, 2026+10.0% EPS-0.7% move
- CAGFY2027 Q1 · September 30, 2026+44.4% EPS-4.9% move
Get the CTSH recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2025-04-16T00:02:45.914612+00:00
- Polygon adjusted daily market bars · 2026-10-07T08:10:44.699399+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-07T08:10:44.696094+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-07. For educational purposes only; not investment advice.